Elicio Therapeutics Cash Flow Statement (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-41.04M	14.32M	-14.81M	-7.34M	-10.23M	-6.05M	-8.15M	-11.25M	-19.72M	-9.77M	-10.62M	-18.84M	-10.30M	-12.84M	-10.86M	-16.64M	-18.37M	-9.18M	-22.00M	-15.64M
Depreciation and Depletion (Quarter)	0.02M	0.04M	0.03M	0.15M	0.10M	0.10M	0.11M	0.10M		0.10M	0.08M	0.10M		0.12M	0.05M	0.10M	0.10M	0.00M	0.05M	0.10M
Share-based Compensation (Quarter)	9.39M	-9.39M	0.03M	0.24M	0.11M	0.20M	0.22M	0.28M	0.34M	0.34M	0.32M	0.35M	0.31M	0.46M	0.52M	0.71M	0.70M	0.77M	0.87M	0.94M
Gains from Investment Securities (Quarter)	-0.13M	-0.27M	-0.04M	0.04M				0.02M	-0.01M	-0.01M	1.28M	-3.62M	5.62M	0.61M	0.51M	0.86M	1.81M	-1.26M	0.98M	-2.48M
Cash from Operations (Quarter)	-15.20M	-14.36M	-15.65M	6.14M	-5.39M	-7.28M	-8.14M	-9.47M	-5.18M	-9.89M	-12.12M	-8.93M	-7.27M	-8.74M	-10.12M	-8.95M	-11.09M	-6.80M	-11.64M	-8.16M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)													0.03M	0.05M	0.04M		0.40M	0.18M	0.07M	0.10M
Amortization of Deferred Charges (Quarter)	1.55M		0.20M	0.09M	0.19M	0.19M		0.40M	0.18M	0.21M	0.21M	0.21M	0.22M	0.22M	0.23M	0.23M	0.23M	0.24M	0.24M	0.25M
Depreciation & Amortization (CF) (Quarter)	0.02M	0.04M	0.03M	0.15M	0.10M	0.10M	0.11M	0.10M		0.10M	0.08M	0.10M		0.12M	0.05M	0.10M	0.10M	0.00M	0.05M	0.10M
Change in Working Capital
Change in Account Payables (Quarter)	-1.66M	-2.94M	-1.32M	3.08M	-0.35M	-0.28M	1.39M	-1.46M	0.14M	-0.04M	-3.26M	-0.05M	0.93M	-0.95M	3.00M	-0.17M	-3.54M	0.35M	-0.46M	0.63M
Change in Accured Expenses (Quarter)	0.84M	-2.17M	2.02M	-1.91M	-0.18M	-0.23M	-0.38M	0.12M	2.16M	0.31M	-0.43M	2.04M	-0.51M	3.56M	-2.65M	-0.66M	0.11M	1.21M	-0.60M	1.47M
Other Working Capital Changes (Quarter)	-0.73M	0.03M	1.51M	-1.50M	1.50M	0.47M	1.22M	-0.13M	-1.04M	0.69M	-1.08M	1.22M	0.44M	-1.42M	0.00M	-1.39M	0.34M	-0.11M	0.50M	0.75M
Investing Activities
Capital Expenditures (Quarter)	-0.01M	-0.03M	-0.03M	0.59M	-0.67M		0.02M	0.00M	0.04M	-0.07M	-0.16M	-1.04M	-1.03M	2.32M			0.17M	-0.15M	0.23M	-0.17M
Sales of Property, Plant and Equipment (Quarter)								0.03M			0.00M
Cash from Investing Activities (Quarter)	-0.06M	-0.04M		-0.56M		-0.10M	-0.02M	0.03M	-0.04M		0.00M	-0.04M		-0.04M				-0.02M
Financing Activities
Other financing activities (Quarter)	0.01M	0.11M		0.08M	-0.06M	0.07M		0.07M	0.06M		6.00M	-5.99M	22.87M	-22.88M	0.01M	-0.01M	1.29M	-1.29M	0.10M	0.02M
Cash from Financing Activities (Quarter)	0.70M	0.40M	-0.01M	1.26M	8.78M	11.18M	10.04M	21.51M	0.06M	7.00M	11.02M	0.32M	30.75M	0.23M	10.33M	11.93M	9.57M	4.86M	8.03M	16.51M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)		-3.07M		1.17M	8.84M	11.11M				7.00M	5.06M	0.30M	0.05M	-0.86M	0.83M	2.02M
Additional items
Exchange Rate Effect (Quarter)	-0.02M	0.01M	-0.09M	0.09M			0.08M	-0.08M	0.00M			-0.04M	0.04M	0.03M	0.03M	0.07M	0.04M	-0.10M	0.01M	-0.00M
Change in Cash (Quarter)	-14.58M	-13.98M	-15.75M	6.92M	3.39M	3.81M	1.88M	12.06M	-5.17M	-2.89M	-1.09M	-8.70M	23.52M	-8.54M	0.24M	3.06M	-1.48M	-2.05M	-3.61M	8.34M
Free Cash Flow (Quarter)	-15.19M	-14.33M	-15.62M	5.55M	-4.71M	-7.28M	-8.16M	-9.48M	-5.23M	-9.83M	-11.96M	-7.89M	-6.24M	-11.06M	-10.12M	-8.95M	-11.26M	-6.64M	-11.87M	-8.00M
Net Cash Flow (Quarter)	-14.56M	-13.99M	-15.67M	6.84M	3.39M	3.81M	1.88M	12.07M	-5.17M	-2.89M	-1.09M	-8.65M	23.48M	-8.56M	0.21M	2.98M	-1.51M	-1.95M	-3.62M	8.35M

Research Tools

Datasets

Plans

Developers

Elicio Therapeutics ELTX Cash Flow Statement (2020-2026)

Research Tools

Datasets

Plans

Developers

Elicio Therapeutics ELTX Cash Flow Statement (2020-2026)

Create an account

Sign In

Reset Password